› Home › About us › Investment philosophy › Our portfolio › Partnerships › News & events › Contact › Career opportunities › Investor login
Meet us at:
Therapeutic antibodies and beyond: celebrating 20 years of display technologies »
Cambridge, UK: September 06- 07, 2010
10th Annual Biotech in Europe Investor Forum »
Zurich, Switzerland: September 29- 30, 2010
 
At Forbion Capital Partners we invest in Life Sciences and Biomedical Technology companies developing world-class drugs and technologies, with a clear focus on product development.

Learn more »

'For Biotech and Beyond'
18.08.2010 AMT’s Marketing Authorisation Application for Glybera® Progressing On Schedule  » 05.08.2010 Argos Therapeutics’ Arcelis™ HIV Immunotherapy Demonstrates Significant Reduction in Viral Load and Delay in Viral Rebound Kinetics in Interim Analysis of Phase 2 Study  » 15.07.2010 ARGEN-X GRANTED BROAD PATENT COVERING ITS UNIQUE SIMPLE ANTIBODYT PLATFORM  »
Pictures

© Forbion 2010 All rights reserved